West Pharmaceutical Services, Inc. (WST)

Last Closing Price: 210.85 (2025-05-30)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

West Pharmaceutical Services, Inc. (WST) had Net Income of $492.70M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$2.89B
Net Income
$492.70M
$1.89B
$998.50M
$2.32B
$569.90M
$15.60M
$585.50M
$585.50M
$478.00M
$492.70M
$492.70M
$478.00M
$569.90M
$725.30M
73.00M
73.70M
$6.75
$6.69
Balance Sheet Financials
$1.54B
$1.58B
$2.11B
$3.64B
$550.40M
$202.60M
$410.70M
$961.10M
$2.68B
$2.57B
$2.68B
72.30M
Cash Flow Statement Financials
$653.40M
$-378.70M
$-622.60M
$853.90M
$484.60M
$-369.30M
$18.70M
$-59.10M
--
Fundamental Metrics & Ratios
2.79
--
--
0.07
0.08
34.51%
19.70%
19.70%
25.07%
20.24%
17.03%
$276.40M
--
--
--
0.79
5.03
5.24
69.70
18.37%
19.20%
13.52%
17.08%
$37.10
$3.75
$8.87